GJB4 and urinary bladder cancer: It has been shown that GJB4 is involved in tumorigenesis and may act as a tumour promoter, Wang et al. (Wang et al., 2019) indicated that miR-492 promoted cancer progression by targeting GJB4 and was a novel biomarker for bladder cancer.